Drug
Imcnyeso
Imcnyeso: highest development phase Phase 1/2, developed by Immunocore. 1 trial record tracked on RxWires.
- Highest phase
- Phase 1/2
- Developer
- Immunocore
Trials
| Drug | Phase | Indication |
|---|---|---|
| IMCnyeso NCT03515551 | Phase 1/2 | Select Advanced Solid Tumors |
Latest
No recent events.
Follow Imcnyeso on RxWires to get trial status changes, FDA actions, filings and patent dates as they happen.
Sourced from ClinicalTrials.gov, openFDA, SEC EDGAR and the FDA Orange Book. Not investment or medical advice.